Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: June 16, 2003
Last updated: April 28, 2009
Last verified: April 2009